基于人参炮制历史沿革探讨中国药典中红参炮制规范  

Study on Processing Standard of Red Ginseng in Chinese Pharmacopoeia Based on Historical Evalution of Ginseng’s Processing

作　　者：鹿扩建 曹欢 笔雪艳[1,2] 张清波 LU Kuojian;CAO Huan;BI Xueyan;ZHANG Qingbo(Heilongjiang University of Chinese Medicine,Harbin 150040,China;Heilongjiang Institute for Drug Control,Harbin 150088,China;Heilongjiang Institute for Drug Evaluation and Risk Monitoring,Harbin 150001,China)

机构地区：[1]黑龙江中医药大学,黑龙江哈尔滨150040 [2]黑龙江省药品检验研究中心,黑龙江哈尔滨150088 [3]黑龙江省药品评价和风险监测中心,黑龙江哈尔滨150001

出　　处：《中国中医药信息杂志》2020年第8期27-29,共3页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：国家药品标准提高暨2015版药典科研任务(2012年)。

摘　　要：为使《中华人民共和国药典》(以下简称“《中国药典》”)红参质量标准规范更加完善,本文通过对人参的炮制历史进行考证及总结、对比与分析历版《中国药典》人参和红参的炮制规范记载,认为红参炮制规范尚有待完善之处,并对2020年版《中国药典》红参炮制规范及用法用量的修订提出建议。The purpose of this study is to revise and perfect the standard specification of red ginseng in the Pharmacopoeia of the People's Republic of China(hereinafter referred to as“Chinese Pharmacopoeia”).By investigating the historical evolution of ginseng's processing,this article summarized the processing standards of ginseng and red ginseng in previous editions of Chinese Pharmacopoeia and compared with each other.It was found that the processing standard of red ginseng still needed to be improved.So the proposal is propounded on the revision and improvement of the processing standard and usage of red ginseng in the Chinese Pharmacopoeia in 2020 in order to make the standard specification of red ginseng in Chinese Pharmacopoeia much perfecter.

关 键 词：人参 红参 中国药典 炮制规范 

分 类 号：R256.69[医药卫生—中医内科学]